{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:49:46Z","timestamp":1792446586566,"version":"4.5.0"},"reference-count":18,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19bk0104002"],"award-info":[{"award-number":["19bk0104002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17bk0104044"],"award-info":[{"award-number":["JP17bk0104044"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20bm0204003"],"award-info":[{"award-number":["JP20bm0204003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>\n                    Despite major therapeutic advances, heart failure, as a non-communicable disease, remains a life-threatening disorder, with 26 million patients worldwide, causing more deaths than cancer. Therefore, novel strategies for the treatment of heart failure continue to be an important clinical need. Based on preclinical studies, allogenic human induced pluripotent stem cell-derived cardiomyocyte (hiPSC-CM) patches have been proposed as a potential therapeutic candidate for heart failure. We report the implantation of allogeneic hiPSC-CM patches in a patient with ischemic cardiomyopathy (\n                    <jats:ext-link>ClinicalTrials.gov<\/jats:ext-link>\n                    , #jRCT2053190081). The patches were produced under clinical-grade conditions and displayed cardiogenic phenotypes and safety\n                    <jats:italic>in vivo<\/jats:italic>\n                    (severe immunodeficient mice) without any genetic mutations in cancer-related genes. The patches were then implanted via thoracotomy into the left ventricle epicardium of the patient under immunosuppressive agents. Positron emission tomography and computed tomography confirmed the potential efficacy and did not detect tumorigenesis in either the heart or other organs. The clinical symptoms improved 6 months after surgery, without any major adverse events, suggesting that the patches were well-tolerated. Furthermore, changes in the wall motion in the transplanted site were recovered, suggesting a favorable prognosis and the potential tolerance to exercise. This study is the first report of a successful transplant of hiPSC-CMs for severe ischemic cardiomyopathy.\n                  <\/jats:p>","DOI":"10.3389\/fcvm.2022.950829","type":"journal-article","created":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T01:52:08Z","timestamp":1660614728000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":112,"title":["Case report: Transplantation of human induced pluripotent stem cell-derived cardiomyocyte patches for ischemic cardiomyopathy"],"prefix":"10.3389","volume":"9","author":[{"given":"Shigeru","family":"Miyagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Kainuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuji","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Iseoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maki","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Sasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Mochizuki-Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Nitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromi","family":"Dohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Watabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nrcardio.2013.212","article-title":"Continue what we are doing to treat HF, but do it better","volume":"11","author":"Cohn","year":"2014","journal-title":"Nat Rev Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/nrcardio.2014.45","article-title":"Heart transplantation with donation after circulatory determination of death","volume":"11","author":"Longnus","year":"2014","journal-title":"Nat Rev Cardiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nrcardio.2012.178","article-title":"Devices in the management of advanced, chronic heart failure","volume":"10","author":"Abraham","year":"2013","journal-title":"Nat Rev Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell."},{"key":"B5","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell."},{"key":"B6","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1161\/CIRCULATIONAHA.111.084343","article-title":"Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model","volume":"126","author":"Kawamura","year":"2012","journal-title":"Circulation."},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1101\/2021.04.07.438744","article-title":"Evaluation of the efficacy and safety of a clinical grade human induced pluripotent stem cell-derived cardiomyocyte patch: a pre-clinical study","volume-title":"bioRxiv [Preprint].","author":"Miyagawa","year":"2021"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/srep03594","article-title":"A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells","volume":"4","author":"Nakagawa","year":"2014","journal-title":"Sci Rep."},{"key":"B9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/978-1-0716-1484-6_4","article-title":"Efficient method to dissociate induced pluripotent stem cell-derived cardiomyocyte aggregates into single cells","volume":"2320","author":"Ito","year":"2021","journal-title":"Methods Mol Biol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1038\/s41598-018-38325-5","article-title":"Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application","volume":"9","author":"Ito","year":"2019","journal-title":"Sci Rep."},{"key":"B11","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0123963","DOI":"10.1371\/journal.pone.0123963","article-title":"Comparison of arrhythmogenicity and proinflammatory activity induced by intramyocardial or epicardial myoblast sheet delivery in a rat model of ischemic heart failure","volume":"10","author":"Patila","year":"2015","journal-title":"PLoS ONE."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3727\/096368914X685799","article-title":"Functional and electrical integration of induced pluripotent stem cell-derived cardiomyocytes in a myocardial infarction rat heart","volume":"24","author":"Higuchi","year":"2015","journal-title":"Cell Transplant."},{"key":"B14","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1089\/ten.tea.2016.0535","article-title":"Pivotal role of non-cardiomyocytes in electromechanical and therapeutic potential of induced pluripotent stem cell-derived engineered cardiac tissue","volume":"24","author":"Iseoka","year":"2018","journal-title":"Tissue Eng Part A."},{"key":"B15","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1152\/physrev.1999.79.2.609","article-title":"Molecular and cellular mechanisms of myocardial stunning","volume":"79","author":"Bolli","year":"1999","journal-title":"Physiol Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1161\/01.CIR.95.7.1900","volume":"95","author":"Fallavollita","year":"1997","journal-title":"Circulation."},{"key":"B17","doi-asserted-by":"publisher","first-page":"4593","DOI":"10.1038\/s41598-020-58126-z","article-title":"Syngeneic mesenchymal stem cells reduce immune rejection after induced pluripotent stem cell-derived allogeneic cardiomyocyte transplantation","volume":"10","author":"Yoshida","year":"2020","journal-title":"Sci Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1161\/CIRCULATIONAHA.112.000366","article-title":"Enhanced survival of transplanted human induced pluripotent stem cell-derived cardiomyocytes by the combination of cell sheets with the pedicled omental flap technique in a porcine heart","volume":"128","author":"Kawamura","year":"2013","journal-title":"Circulation."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.950829\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T01:52:14Z","timestamp":1660614734000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.950829\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":18,"alternative-id":["10.3389\/fcvm.2022.950829"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.950829","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.12.27.21268295","asserted-by":"object"}]},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"article-number":"950829"}}